Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Nash

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|June 1, 1993
Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemiaR H Bradford, M Downton, A N Chremos, et al.
Circulation|April 1, 1992
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteinsC L Shear, F A Franklin, S Stinnett, et al.
Circulation|May 12, 1998
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trialF M Sacks, L A Moyé, B R Davis, et al.
Archives of Internal Medicine|May 2, 2000
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study GroupJ R Guyton, M A Blazing, J Hagar, et al.
American Heart Journal|June 1, 1993
Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertensionJ L Mehta, L M Lopez, N D Vlachakis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertensionJ L Pool, J Gennari, R Goldstein, et al.
The American Journal of Medicine|July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatinC A Dujovne, A N Chremos, J L Pool, et al.
The American Journal of Cardiology|October 1, 1994
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-upR H Bradford, C L Shear, A N Chremos, et al.
The American Journal of Cardiology|March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levelsF M Sacks, J L Rouleau, L A Moye, et al.
The American Journal of Medicine|July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|June 1, 1993
Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemiaR H Bradford, M Downton, A N Chremos, et al.
Circulation|April 1, 1992
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteinsC L Shear, F A Franklin, S Stinnett, et al.
Circulation|May 12, 1998
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trialF M Sacks, L A Moyé, B R Davis, et al.
Archives of Internal Medicine|May 2, 2000
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study GroupJ R Guyton, M A Blazing, J Hagar, et al.
American Heart Journal|June 1, 1993
Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertensionJ L Mehta, L M Lopez, N D Vlachakis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertensionJ L Pool, J Gennari, R Goldstein, et al.
The American Journal of Medicine|July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatinC A Dujovne, A N Chremos, J L Pool, et al.
The American Journal of Cardiology|October 1, 1994
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-upR H Bradford, C L Shear, A N Chremos, et al.
The American Journal of Cardiology|March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levelsF M Sacks, J L Rouleau, L A Moye, et al.
The American Journal of Medicine|July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.
Pageof 7